Feboxit 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and the formation of urate crystals in joints and tissues. Feboxit 40 is typically prescribed for patients who have not responded adequately to other urate-lowering therapies or those who are intolerant to allopurinol. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities; therefore, regular monitoring of liver function tests is recommended during treatment. Feboxostat is contraindicated in patients with severe liver impairment and those with a history of hypersensitivity to the drug. Patients should inform their doctor of any other medications they are taking to avoid potential drug interactions. Feboxit 40 offers an effective option for long-term management of gout by controlling uric acid levels and reducing the frequency of painful flare-ups.